Detection of HTLV-I tax-rex and pol gene sequences of thymus gland in a large group of patients with myasthenia gravis.

We report in this study the use of polymerase chain reaction (PCR) for the amplification of the genomic DNA, isolated from thymic tissue, using the primers flanking HTLV-I/II tax-rex genes and the sequence method to analyze the HTLV-I pol sequence of 27 Italian patients with myasthenia gravis. These molecular methods showed that 92.5% of patients tested positive for tax gene and 55% for pol genes; 55.5% samples were positive for both the tax gene of HTLV-I/II, and the pol gene of HTLV-I. Histologic investigation of the thymus showed that 15 samples had thymic hyperplasia, 93% tested positive for the tax gene, and 40% tested positive for both the tax and pol genes of HTLV-I. In contrast, 91.6% of thymoma-positive samples were positive for tax gene I/II and 75% positive for both genes, tax and pol type I. The sequence analysis of PCR product for tax and pol genes confirmed that these amplified products were HTLV-I, with minimal variations. Our date suggested that either HTLV-I or part of the virus genome is involved in the etiopathogenesis of myasthenia gravis.

[1]  Y. Iwakura,et al.  Involvement of autoimmunity against type II collagen in the development of arthritis in mice transgenic for the human T cell leukemia virus type I tax gene , 1999, European journal of immunology.

[2]  P. Höllsberg.  Pathogenesis of chronic progressive myelopathy associated with human T‐cell lymphotropic virus type I , 1997, Acta neurologica Scandinavica. Supplementum.

[3]  T. Sumida,et al.  Human T lymphotropic virus type I in arthropathy and autoimmune disorders. , 1996, Arthritis and rheumatism.

[4]  A. Nishio,et al.  Myasthenia gravis, acute transverse myelitis, and HTLV-I , 1995, Journal of the Neurological Sciences.

[5]  N. Calcutt,et al.  Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction , 1995, The Journal of experimental medicine.

[6]  A. Glukhov,et al.  Persistence of human T cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides [published erratum appears in J Exp Med 1995 Jan 1;181(1):441] , 1994, The Journal of experimental medicine.

[7]  H. Tsukagoshi,et al.  Human T lymphotropic virus type I associated myelopathy and myasthenia gravis: a possible association? , 1994, European neurology.

[8]  K. Murphy,et al.  T-cell subsets in autoimmunity. , 1993, Current opinion in immunology.

[9]  H. Pircher,et al.  Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. , 1993, Journal of immunology.

[10]  M. Reitz,et al.  Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Hirofumi Kawabe,et al.  A Comparison between Argon‐dye and Excimer‐dye Laser for Photodynamic Effect in Transplanted Mouse Tumor , 1992, Japanese journal of cancer research : Gann.

[12]  M. Goldman,et al.  TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. , 1991, Immunology today.

[13]  W. Blattner,et al.  Infective dermatitis of Jamaican children: a marker for HTLV-I infection , 1990, The Lancet.

[14]  M. Sporn,et al.  Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia , 1990, The Journal of experimental medicine.

[15]  Samuel H. Wilson,et al.  HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. , 1990, Science.

[16]  C. Mora,et al.  HTLV-1 AND POLYMYOSITIS IN JAMAICA , 1989, The Lancet.

[17]  I. Maruyama,et al.  CHRONIC INFLAMMATORY ARTHROPATHY ASSOCIATED WITH HTLV-I , 1989, The Lancet.

[18]  N. Monplaisir,et al.  T-LYMPHOCYTE ALVEOLITIS, TROPICAL SPASTIC PARESIS, AND SJÖGREN SYNDROME , 1988, The Lancet.

[19]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[20]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[21]  J. Wolinsky,et al.  Attempts to implicate viruses in myasthenia gravis , 1985, Neurology.

[22]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[23]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[24]  Hoffbrand Bi.  Beta-adrenergic blockage in congestive cardiomyopathy. , 1980 .

[25]  Christie Ad.  Letter: Fetal cephalometry. , 1974 .

[26]  Backworth Tc.  Psychiatric Reports: whether and how. , 1966 .

[27]  R. Magendie,et al.  History of a Case of Hydrophobia, treated at the Hotel Dieu at Paris, by an injection of water into the veins. , 1823 .

[28]  D. Dickson,et al.  Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations , 2004, Acta Neuropathologica.

[29]  T. Sumida,et al.  Evidence for autoantigens of Env/Tax proteins in human T cell leukemia virus type I Env-pX transgenic mice. , 1998, Arthritis and rheumatism.

[30]  R. Hohlfeld,et al.  The role of the thymus in myasthenia gravis. , 1994, Advances in neuroimmunology.